NEW YORK (GenomeWeb) – Sequenom reported after the close of the market on Wednesday that its first quarter revenues rose 2 percent year over year.

The San Diego-based molecular diagnostics company reported Q1 revenues of $37.8 million compared to $37.1 million in Q1 2014, missing the Wall Street consensus estimate of $38.6 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.